Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini, Elissavet Kardami
Oncotarget (2017) Vol. 8, Iss. 28, pp. 46663-46680
Open Access | Times Cited: 273

Showing 1-25 of 273 citing articles:

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Pushkar Singh Rawat, Aiswarya Jaiswal, Amit Khurana, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111708-111708
Open Access | Times Cited: 569
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace, Vilma A. Sardão, Paulo J. Oliveira
Circulation Research (2020) Vol. 126, Iss. 7, pp. 926-941
Open Access | Times Cited: 427
Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
Balaraman Kalyanaraman
Redox Biology (2019) Vol. 29, pp. 101394-101394
Open Access | Times Cited: 279
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth
Mingchuan Li, Valentina Sala, Maria Chiara De Santis, et al.
Circulation (2018) Vol. 138, Iss. 7, pp. 696-711
Open Access | Times Cited: 179
Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway
Jian Yin, Jiabin Guo, Qiang Zhang, et al.
Toxicology in Vitro (2018) Vol. 51, pp. 1-10
Closed Access | Times Cited: 169
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah, Shafiul Alam, Richa Aishwarya, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 156
Doxorubicin‐induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy
Michael P. Catanzaro, Ashley A. Weiner, Amanda Kaminaris, et al.
The FASEB Journal (2019) Vol. 33, Iss. 10, pp. 11096-11108
Open Access | Times Cited: 146
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Kerstin N. Timm, Damian J. Tyler
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 2, pp. 255-269
Open Access | Times Cited: 145
Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy
Renye Yue, Cheng Zhang, Li Xu, et al.
Chem (2022) Vol. 8, Iss. 7, pp. 1956-1981
Open Access | Times Cited: 99
Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation
Nonhlakanipho F. Sangweni, Kwazi Gabuza, Barbara Huisamen, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1541-1550
Open Access | Times Cited: 70
Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy
Ye Chen‐Izu, Saixian Shi, Yan Dai
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113903-113903
Open Access | Times Cited: 70
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Xiaopeng Zhao, Zheng Tian, Mingli Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 42
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
Rita Zilinyi, Attila Czompa, András Czeglédi, et al.
Molecules (2018) Vol. 23, Iss. 5, pp. 1184-1184
Open Access | Times Cited: 158
Marine Sponge Natural Products with Anticancer Potential: An Updated Review
Cinzia Calcabrini, Elena Catanzaro, Anupam Bishayee, et al.
Marine Drugs (2017) Vol. 15, Iss. 10, pp. 310-310
Open Access | Times Cited: 136
Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance
Hamdan S. Al-malky, Sameer E Al Harthi, Abdel‐Moneim M. Osman
Journal of Oncology Pharmacy Practice (2019) Vol. 26, Iss. 2, pp. 434-444
Closed Access | Times Cited: 133
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Konrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 309-332
Closed Access | Times Cited: 133
p53 and metabolism: from mechanism to therapeutics
Fernando Moreira Simabuco, Mirian Galliote Morale, Isadora Carolina Betim Pavan, et al.
Oncotarget (2018) Vol. 9, Iss. 34, pp. 23780-23823
Open Access | Times Cited: 128
Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases
Parama Dey, Monikongkona Boruah, Kumari Yachna, et al.
Life Sciences (2020) Vol. 260, pp. 118182-118182
Closed Access | Times Cited: 122
Oxidized phospholipids in Doxorubicin-induced cardiotoxicity
Navid Koleini, Barbara E. Nickel, Andrea L. Edel, et al.
Chemico-Biological Interactions (2019) Vol. 303, pp. 35-39
Closed Access | Times Cited: 118
Autophagy and cardiac diseases: Therapeutic potential of natural products
Xiaoqian Wu, Zumei Liu, Xi‐Yong Yu, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 314-341
Closed Access | Times Cited: 107
Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice
Zhimeng Xu, Cheng-Bin Li, Qing-Ling Liu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3658-3658
Open Access | Times Cited: 104
Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
Nanthip Prathumsap, Krekwit Shinlapawittayatorn, Siriporn C. Chattipakorn, et al.
European Journal of Pharmacology (2019) Vol. 866, pp. 172818-172818
Closed Access | Times Cited: 97
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
Haixia Xu, Wenjun Yu, Shiqun Sun, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 95
Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection
Branislav Kura, Barbora Kaločayová, Yvan Devaux, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 700-700
Open Access | Times Cited: 86
SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
Panxia Wang, Luping Wang, Jing Lü, et al.
Journal of Molecular and Cellular Cardiology (2019) Vol. 133, pp. 125-137
Closed Access | Times Cited: 82
Page 1 - Next Page

Scroll to top